Bioheart, Inc. Announces Successful Grand Opening Of Facility In South Africa

Bioheart, Inc. , a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces a successful grand opening of the laboratory and clinic in South Africa. The new facility, named South African Stem Cell Institute , immediately began treating patients.

http://ift.tt/1mTPfOI